drugset / Trial / NCT07376148

Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30

NCT07376148

NaSingle-groupOpen-labelTreatment

Summary

Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.

Timeline

Start
2025-11-07
Primary completion
2026-02-28
Completion
2026-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified Topical
Subject Vitamin C Other / unclassified Topical
Subject sodium DNA Unknown Topical

Indications